National Institutes of Health

GreenMark Biomedical Inc. is a minimally invasive healthcare company focused on developing innovative technologies utilizing biopolymer nanoparticles derived from natural starch. Founded in 2016 and based in East Lansing, Michigan, with a laboratory in Ann Arbor, the company specializes in dental and medical applications. Its dental technologies include a mouth rinse product that illuminates cavities and early-stage lesions, allowing dentists to accurately diagnose and treat tooth decay. Additionally, GreenMark's medical technologies are designed for targeted delivery of anti-cancer drugs, enhancing treatment precision. The company aims to provide health benefits through its advanced nanoparticle-based solutions, promoting less invasive and more effective healthcare practices.

SonoMotion Inc. is a medical device company focused on developing non-invasive solutions for kidney stone disease. Founded in 2012 and based in San Mateo, California, the company offers innovative products like Break Wave, which effectively fragments large kidney stones, and Stone Clear, designed to clear the resulting fragments within 15 minutes in an office setting without the need for general anesthesia or X-ray radiation. Additionally, SonoMotion is advancing its technology with a stone repositioning solution currently in clinical trials and a second-generation stone breaking technology in development. The company's mission is to provide caregivers with safe, efficient, and cost-effective treatment options for patients suffering from kidney-related ailments.

Comprised of Ronald Reagan UCLA Medical Center, UCLA Medical Center, Santa Monica; Resnick Neuropsychiatric Hospital at UCLA, Mattel Children's Hospital UCLA, and the UCLA Medical Group with its wide-reaching system of primary-care and specialty-care offices throughout the region, UCLA Health System is among the most comprehensive and advanced healthcare systems in the world.

IVOS Medical is an innovative medical device company focused on advancing airway management technology.

Vast Therapeutics, Inc. is a preclinical-stage pharmaceutical company based in Durham, North Carolina, focused on developing inhalable treatments for antibiotic-resistant pathogens affecting patients with cystic fibrosis and other respiratory diseases. Established in 2017 and previously known as Novoclem Therapeutics, the company aims to address chronic infections that are prevalent in the cystic fibrosis population. Vast Therapeutics operates as a subsidiary of KNOW Bio, LLC, and is dedicated to advancing its innovative therapeutic solutions to improve health outcomes for patients facing these challenging conditions.

Arkansas Children's Research Institute is a not-for-profit organization affiliated with Arkansas Children's, Inc., and is dedicated to advancing pediatric health through research. It operates in conjunction with Arkansas Children's Hospital, the only pediatric medical center in Arkansas and one of the largest in the nation, which spans 29 city blocks and features 370 beds. The hospital employs around 500 physicians and more than 4,400 staff members, focusing on innovative medical research, surgical procedures, and intensive treatments aimed at improving children's health and development. The institute's research efforts contribute to the hospital's reputation for medical breakthroughs and have garnered recognition, including being ranked on the FORTUNE 100 Best Companies to Work For list for three consecutive years.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Rhealth is a biotechnology company that specializes in health management solutions by leveraging advanced artificial intelligence. It offers a platform designed for hospitals, facilitating the delivery of comprehensive health information to both physicians and patients. The company's innovative technologies transform the accessibility of analytical and diagnostic information, integrating portable diagnostic and monitoring capabilities. This enables healthcare providers to offer improved and timely health information, ultimately enhancing patient care.

The University of Louisville is a public research university offering a range of undergraduate and graduate programs across various disciplines. It is committed to advancing knowledge through research in fields such as health, engineering, and the humanities. The university actively collaborates with community partners to enhance its academic and research initiatives, thereby contributing to the education, healthcare, and research sectors. Additionally, the University of Louisville School of Dentistry operates as a specialized institute within the university, focusing on dental education and practice.

University of Arkansas for Medical Sciences is an academic health center focusing on medical education, research, and clinical programs. It offers various medical services, including specialized care in areas such as women's health, cancer treatment, orthopedics, stroke care, and trauma.

Scripps Health is a private, nonprofit integrated health system based in San Diego, California. It is dedicated to delivering high-quality medical care and services to individuals and families, encompassing a range of healthcare needs from preventive services to specialized treatments. Scripps Health operates several top-ranked hospitals and provides access to some of the best medical professionals in the region. The organization emphasizes wellness screenings and comprehensive care at every stage of life, ensuring that community members receive the support they need for their health and well-being. Additionally, the Scripps Health Foundation plays a crucial role in facilitating philanthropic efforts that enhance the quality of patient care within the system.

Elimu Informatics is a company that develops cloud-based clinical decision support software aimed at healthcare professionals. The firm focuses on enhancing the quality of patient care, improving patient experience, and ensuring usability through its expertise in clinical decision support, semantic normalization, and workflow integration. By providing these solutions, Elimu Informatics enables healthcare organizations to optimize their operations without the need for extensive development costs or lengthy implementation timelines.

BioCircuit Technologies, Inc. is a medical device company based in Atlanta, Georgia, founded in 2016. The company specializes in developing noninvasive electrophysiology devices that monitor, control, and repair peripheral nerves. By utilizing multi-electrode arrays and proprietary algorithms, BioCircuit's products enable clinicians to diagnose health conditions more effectively, track the progression of symptoms over time, and select tailored treatments for individual patients. This innovative approach enhances the ability of healthcare providers to address nerve-related health issues with greater precision and efficiency.

BMI OrganBank is a company that specializes in the development of innovative medical devices and perfusion technology aimed at enhancing the preservation of organs and tissues for transplantation. By collaborating with academic institutions, the company seeks to expand the potential of organ transplantation and improve outcomes for patients in need. BMI OrganBank is particularly focused on transforming kidney transplantation and advancing organ preservation methods, with the goal of benefiting thousands of patients awaiting transplants. Additionally, the company is involved in creating technologies such as lung ventilators and ex vivo tissue perfusion systems, which are designed to enable healthcare providers to deliver improved medical care.

Sparian Biosciences is an early-stage biopharmaceutical company dedicated to the discovery and development of innovative therapies for the central nervous system (CNS). The firm specializes in creating unique and transformative medicines that specifically target brain-related conditions. Sparian is committed to advancing therapeutic solutions that address both acute and chronic pain through cutting-edge science and novel drug discovery methods.

Mount Sinai Health System is an integrated healthcare system based in New York, providing exceptional medical care to local and global communities. Established in 2013 through the merger of Mount Sinai Medical Center and Continuum Health Partners, it encompasses the Icahn School of Medicine and operates seven hospital campuses throughout the New York metropolitan area. The system is recognized for its excellence in research, patient care, and education across various specialties. It features a vast network of over 7,000 primary and specialty care physicians, as well as more than 45 ambulatory practices and 12 minority-owned free-standing ambulatory surgery centers. Mount Sinai is committed to improving healthcare quality and accessibility, focusing on compassionate patient experiences and the development of strong relationships between staff and patients. Additionally, its venture capital arm, Mount Sinai Ventures, invests in healthcare startups, further enhancing its capacity to innovate and respond to the diverse health needs of the populations it serves.

ReShape Medical Inc. is a medical device company headquartered in San Clemente, California, specializing in non-surgical weight loss solutions. The company offers the ReShape Integrated Dual Balloon System, which employs dual balloon technology to aid weight loss in adults with a Body Mass Index (BMI) of 30-40 who have not achieved success with diet and exercise alone. This procedure is complemented by a personalized weight loss program that lasts one year. The company's product line includes the FDA-approved Lap-Band System, a minimally invasive treatment for obesity, and the investigational ReShape Vest System, designed to wrap around the stomach and induce weight loss without permanently altering patient anatomy. ReShape Medical's portfolio aims to provide effective alternatives to invasive surgical procedures for managing obesity and related metabolic diseases. The company operates as a subsidiary of EnteroMedics Inc., having undergone a name change in 2017.

Brixton Biosciences is a clinical-stage life sciences company focused on developing innovative therapies for pain management. The company addresses significant unmet needs in both chronic and acute pain treatment, moving beyond traditional systemic approaches. Its flagship product, Neural Ice™, is a drug-free injectable therapy designed to provide safe and effective pain relief through reversible inhibition of nerve activity. This novel solution offers patients a long-lasting relief period, with effectiveness extending from thirty to sixty days following a single injection. By prioritizing non-addictive and locally targeted therapies, Brixton Biosciences aims to transform pain management practices and improve the quality of life for patients suffering from various forms of pain.

Young Heart Valve is a Polymeric, Hyaluronan-Enhanced Transcatheter Aortic Valves which were developed by engineers with inspiration from nature. The future of heart valve intervention is being altered by Young Heart Valve. Animal tissue is no longer required thanks to Young Heart Valve. Hyaluronan is included into the leaflets of Young Heart Valve's RejuvenateTM TAVR device, forming a biomolecular interpenetrated network that has been shown to be resistant to calcification and thrombosis.

Caretaker Medical, LLC is a developer and manufacturer of wireless patient monitoring devices, based in Charlottesville, Virginia, with additional locations in Surrey, United Kingdom, and Beijing, China. The company offers an innovative wearable monitoring system that utilizes a simple finger cuff to continuously measure vital signs such as blood pressure, heart rate, respiration rate, and other hemodynamic parameters. This device allows clinicians to securely transmit data over cellular networks or Bluetooth, enabling real-time monitoring and improving patient outcomes across the continuum of care—within hospitals, during transport, and after discharge. The system is designed to enhance mobility, simplicity, and cost-effectiveness while ensuring compliance with health regulations. By providing accurate, ICU-level monitoring in a non-invasive format, Caretaker Medical aims to improve patient comfort and facilitate better healthcare delivery.

Teal Health is dedicated to improving women's health by providing innovative solutions, starting with at-home cervical cancer screenings. The company has developed the first FDA-approved device that allows women to perform cervical cancer screenings in the comfort and privacy of their own homes. By simplifying the screening process, Teal Health aims to encourage timely screenings and promote early treatment, ultimately working towards the eradication of cervical cancer in the United States. The company's mission focuses on designing health solutions that cater to women's preferences and experiences, addressing the pressing issues in women's health with a commitment to empowerment and accessibility.

Pip Care is a healthcare company that specializes in enhancing the surgical experience through its personalized surgical journey platform. This platform collaborates with health systems to streamline the perioperative care process, supporting both care teams and patients from the preparation phase through recovery. Pip Care offers a perioperative care app that assists patients in preparing for surgery and facilitates their recovery, featuring certified health coaches who develop individualized care plans. These plans include daily tasks and tailored advice, helping patients manage appointments and feel more empowered and prepared for their surgical procedures. By focusing on the digitization and automation of existing perioperative workflows, Pip Care aims to improve surgical outcomes for patients while also enhancing the financial performance of health systems.

Arkansas Children's Research Institute is a not-for-profit organization affiliated with Arkansas Children's, Inc., and is dedicated to advancing pediatric health through research. It operates in conjunction with Arkansas Children's Hospital, the only pediatric medical center in Arkansas and one of the largest in the nation, which spans 29 city blocks and features 370 beds. The hospital employs around 500 physicians and more than 4,400 staff members, focusing on innovative medical research, surgical procedures, and intensive treatments aimed at improving children's health and development. The institute's research efforts contribute to the hospital's reputation for medical breakthroughs and have garnered recognition, including being ranked on the FORTUNE 100 Best Companies to Work For list for three consecutive years.

CardieX Limited is a global health technology company specializing in cardiovascular health management. Founded in 1994 and headquartered in Sydney, Australia, the company designs, manufactures, and markets medical devices aimed at measuring patient risk for hypertension, cardiovascular disease, and other vascular disorders. Its product offerings include devices that utilize patented SphygmoCor technology to assess arterial stiffness and central blood pressure waveforms. Additionally, CardieX develops the Arty platform, which provides physiological and health analytics for wearable devices. The company also offers TeleHealth Services, connecting patients with health coaches through digital and mobile tools. CardieX's solutions are provided to hospitals, clinics, research institutions, and pharmaceutical companies globally. The company has strategic partnerships, including a collaboration with Blumio Inc. for developing wearable sensors and a joint development agreement with inHealth for hypertension and cardiovascular programs. CardieX was previously known as AtCor Medical Holdings Limited until its name change in June 2018.

Allyx Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2018 and based in Durham, Connecticut. The company specializes in developing disease-modifying treatments for Alzheimer's Disease, with a focus on reversing neurodegeneration. Its lead product is an orally bioavailable small molecule that functions as a silent allosteric modulator of mGluR5. This innovative approach aims to provide clinicians with a therapeutic option capable of preserving cognition in patients while addressing the underlying disease mechanisms.

Southern California University of Health Sciences has been a leader in educating students to be competent and caring integrative healthcare practitioners for over 100 years. SCU has a history of providing the highest levels of patient care and has gained a reputation for excellence in an evidenceinformed curriculum. SCU is the best place to prepare for a successful, significant, and rewarding career.

The Instituto Nacional de Salud Publica is an academic institution whose central commitment to Mexican society is to provide research results to relevant public health problems in order to prevent and control diseases, as well as to train health professionals who help promote healthy living conditions in the community's various groups. population.

Rosalind Franklin University of Medicine and Science, established in 1912, is a North Chicago, Illinois-based institution dedicated to educating future health science leaders. It comprises five schools offering degrees such as Doctor of Medicine, Doctor of Podiatric Medicine, Nurse Anesthesia, Physical Therapy, and Physician's Assistant. The university fosters research and provides opportunities for students to engage in it, both on campus and through partnerships with nearby institutions. It aims to enrich students' lives professionally, mentally, and socially through various organizations and activities. Admission requirements vary by school but generally seek students with a strong scientific background and leadership skills. The university offers financial aid to eligible students who demonstrate need.

Amissa develops mobile and wearable application solutions aimed at alleviating the challenges of Alzheimer's care. The company’s technology empowers caregivers by allowing them to geo-fence and locate loved ones who may wander, remotely monitor their activity and health, and predict behaviors associated with Alzheimer's. In addition to these features, Amissa offers wearable biosensors integrated with a cloud-based data platform that collects biometric data on activity levels, sleep patterns, and physiological changes. This comprehensive approach not only aids caregivers in monitoring patients but also provides valuable insights for researchers seeking to understand disease progression, ultimately enhancing the quality of life for individuals with dementia and related disorders.

The Oklahoma Medical Research Foundation (OMRF) is a non-profit biomedical research institute dedicated to understanding and treating various devastating illnesses, including Alzheimer's, heart disease, lupus, multiple sclerosis, and cancer. It operates a research facility, providing services and access to resources that facilitate drug discoveries and improve patient care.

Resvita Bio is a biotechnology company focused on developing and manufacturing engineered probiotics specifically designed to treat various skin-related diseases, including cancer. The company utilizes synthetic biology and metabolic engineering to create a versatile skin microbial platform. This platform aims to deliver therapies that reduce inflammation, repair damaged tissue, and eliminate harmful bacteria, offering faster and more effective treatment options for chronic skin conditions.

Lasarrus is a medical device company founded in 2013 and headquartered in Baltimore, Maryland. The company specializes in developing wearable devices aimed at enhancing the physical therapy experience for patients, particularly those with chronic obstructive pulmonary disease. Lasarrus's innovative device facilitates remote monitoring and telemedicine by capturing physiological and range-of-motion data from various points on the body. This technology provides patients with an affordable, comfortable, and non-invasive means to track their health routines and accelerate their recovery process.

TransCode Therapeutics, founded in 2016 and based in Boston, Massachusetts, is a biopharmaceutical company dedicated to discovering, developing, and commercializing microRNA (miRNAs) therapeutics for treating metastatic cancer. The company's core focus lies in its proprietary TTX nanoparticle platform, which enables the intelligent design and effective delivery of RNA therapeutics targeting specific miRNAs. TransCode's lead candidate, TTX-MC138, targets microRNA-10b, a validated biomarker of metastasis across multiple tumor types. By inhibiting this miRNA, TransCode aims to eradicate metastatic tumor cells and combat cancer progression.

Subtle Medical, Inc. is a healthcare technology company based in Menlo Park, California, specializing in AI-powered medical imaging solutions. Founded in 2017, the company develops innovative software products such as SubtleMR and SubtlePET, which are designed to enhance image quality in magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. These products utilize proprietary deep learning algorithms to reduce image noise and improve sharpness, thereby increasing efficiency and safety in clinical workflows. Subtle Medical's technology is FDA cleared and CE marked, and it operates on a vendor-agnostic AI infrastructure that integrates seamlessly with existing imaging systems. The company's mission is to enhance the quality, value, and accessibility of medical imaging by lowering costs, reducing imaging time, and minimizing radiation and contrast doses for patients.

Precision Epigenomics, established in 2020 and based in Tucson, Arizona, specializes in molecular diagnostics for cancer. The company focuses on developing innovative molecular diagnostic assays, leveraging DNA methylation analysis, an epigenetic modification, to enhance cancer diagnosis and treatment. Their offerings aim to address unmet clinical needs, aiding clinicians in improved patient management.

Immunovia is a diagnostics company focused on the early detection of pancreatic cancer and other complex diseases. It develops and commercializes innovative diagnostic tools using its proprietary technology platform, IMMray, which is based on antibody microarray analysis. The company conducts clinical trials and validation studies to ensure the accuracy and reliability of its tests. By collaborating with medical institutions and research centers worldwide, Immunovia aims to bring its diagnostic solutions to market, significantly impacting the treatment and management of pancreatic cancer and potentially improving survival rates. Its approach to utilizing blood-based biomarkers may also enable early detection strategies for other cancers and autoimmune diseases.

University of Arkansas for Medical Sciences is an academic health center focusing on medical education, research, and clinical programs. It offers various medical services, including specialized care in areas such as women's health, cancer treatment, orthopedics, stroke care, and trauma.

Cortechs.ai is a developer of brain image analysis software that enhances clinical insight through quantitative imaging. The company's innovative solutions are utilized by neurologists and radiologists in numerous clinics and research centers globally. Its software provides a practical and cost-effective approach to quantifying brain structures, aiding medical professionals in the evaluation of various neurological conditions, including Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury. Through its advanced imaging technology, Cortechs.ai aims to improve diagnostic accuracy and treatment outcomes in the field of neurology.

Anebulo Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative treatments for individuals experiencing cannabinoid overdose and substance addiction. Its primary product candidate, ANEB-001, is designed to counteract the adverse effects of cannabinoid overdose within one hour of administration. Clinical trials indicate that ANEB-001 is quickly absorbed and well-tolerated, with additional benefits such as weight loss, which aligns with its action as a central cannabinoid receptor type 1 antagonist. The company aims to address a significant medical need, as symptoms of cannabinoid overdose can vary widely, including severe sedation, anxiety, panic, and psychotic episodes with hallucinations.

MaMome is dedicated to advancing women's health, beginning with pregnancy, and extending beyond, by utilizing microbiome coupled with machine learning/AI, we precisely identify expectant mothers at elevated risk of pregnancy complications.

Arkansas Children's Research Institute is a not-for-profit organization affiliated with Arkansas Children's, Inc., and is dedicated to advancing pediatric health through research. It operates in conjunction with Arkansas Children's Hospital, the only pediatric medical center in Arkansas and one of the largest in the nation, which spans 29 city blocks and features 370 beds. The hospital employs around 500 physicians and more than 4,400 staff members, focusing on innovative medical research, surgical procedures, and intensive treatments aimed at improving children's health and development. The institute's research efforts contribute to the hospital's reputation for medical breakthroughs and have garnered recognition, including being ranked on the FORTUNE 100 Best Companies to Work For list for three consecutive years.

Weill Cornell Medicine operates as a prestigious medical and graduate school in New York City, dedicated to excellence in education, patient care, and scientific discovery. The institution provides a wide array of services, including medical consultancy, healthcare programs, and educational opportunities for future physicians and medical professionals. It is also involved in the management of specialized treatment centers, such as the Weill Cornell Vein Treatment Center, which addresses various venous conditions and related health issues. In addition to its clinical services, Weill Cornell Medicine emphasizes the integration of advanced technology in its operations, supported by a robust Information Technologies & Services Department. This department enhances the institution's mission by providing comprehensive IT infrastructure and support, including the development of innovative applications for clinical and research projects. Through its multidisciplinary approach, Weill Cornell Medicine serves as a vital resource for healthcare providers, medical students, and researchers, facilitating access to medical education and advisory services across various health-related fields.

VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, the company specializes in developing bioresorbable smart polymers specifically designed for vascular surgery. Its flagship product, SelfWrap, is a perivascular wrap that functions as an external stent to enhance the success of dialysis procedures. SelfWrap addresses complications at the vein-artery or vein-graft junction by promoting outward vein growth and providing customized mechanical support, thereby reducing the risk of vein collapse and occlusion. This innovative approach utilizes a new class of shape-memory polymers that do not require sutures, ultimately improving surgical outcomes, reducing operation time, and minimizing infection risks for hemodialysis patients. VenoStent aims to significantly impact the approximately 5 million vascular surgeries conducted annually, enhancing the quality and longevity of life for chronic kidney disease patients.

CUNY SPH promotes and sustains healthier populations in their city and around the world through education, research, and service in public health. They offer essential insights into public health problems and solutions. They believe collaboration leads to innovative and impactful research, programs, and policies.

Preeclampsia Foundation is a nonprofit that focuses on reducing maternal and infant illness and death due to preeclampsia.

Phenomix Sciences is a biotechnology company founded in 2017 and headquartered in New York, United States. It specializes in the fields of metabolomics and genomics, focusing on developing healthcare solutions for personalized management of chronic diseases. The company has created a data analysis platform aimed at precision medicinal research for obesity management, which features a novel blood test and an AI-driven algorithm. This platform classifies the unique pathophysiological phenotype of patients with obesity, providing healthcare centers with tools and services that enhance the efficacy of obesity management while also reducing side effects and overall costs.

Arkansas Children's Research Institute is a not-for-profit organization affiliated with Arkansas Children's, Inc., and is dedicated to advancing pediatric health through research. It operates in conjunction with Arkansas Children's Hospital, the only pediatric medical center in Arkansas and one of the largest in the nation, which spans 29 city blocks and features 370 beds. The hospital employs around 500 physicians and more than 4,400 staff members, focusing on innovative medical research, surgical procedures, and intensive treatments aimed at improving children's health and development. The institute's research efforts contribute to the hospital's reputation for medical breakthroughs and have garnered recognition, including being ranked on the FORTUNE 100 Best Companies to Work For list for three consecutive years.

Selsym Biotech is a biotechnology company focused on developing innovative therapies for uncontrolled bleeding. Their primary product, Hemostatic Healing Hydrogels (H3), is designed to control bleeding in trauma and surgery situations. This therapy addresses critical issues such as platelet supply shortages and shelf life limitations, aiming to revolutionize hemorrhage control in emergency and surgical settings.

The University of California San Diego (UC San Diego) is a public research university renowned for its diverse undergraduate and graduate programs across multiple disciplines. It emphasizes research, community engagement, and interdisciplinary collaboration, making it a hub for innovation and education. The university houses the School of Medicine, which prepares students for careers in healthcare by equipping them with the necessary knowledge and skills to become dedicated medical professionals. Additionally, UC San Diego fosters a multidisciplinary approach to complex systems through its human-centered design thinking labs, collaborating with various industrial partners in fields such as automation and healthcare. It actively supports student involvement in leadership and offers resources for studying abroad, enhancing the overall educational experience.

University of Arkansas for Medical Sciences is an academic health center focusing on medical education, research, and clinical programs. It offers various medical services, including specialized care in areas such as women's health, cancer treatment, orthopedics, stroke care, and trauma.

Annoviant is a healthcare company focused on the development of innovative medical devices, specifically tissue-based valve and conduit replacement systems. These devices are designed to address congenital deficiencies by replacing or patching structures that are either absent or underdeveloped. Annoviant's products are characterized by their regenerative capabilities, as well as their resistance to thrombosis, calcification, and infection. By maintaining essential mechanical properties, these devices empower clinicians to enhance clinical outcomes for substitute conduit arteries in infants and children, significantly reducing the likelihood of repeat surgeries.

The Feinstein Institutes is a research services centre.

Cincinnati Children’s Hospital Medical Center is a leading institution dedicated to improving child health, attracting patients and families both regionally and internationally. Recognized for its expertise, the hospital serves as a referral center for complex surgical procedures and treatments for rare pediatric diseases. The center is committed to advancing pediatric medicine by discovering innovative and effective treatment methods, solidifying its reputation as one of the foremost facilities for pediatric care globally.

Springbok Analytics offers an AI-powered software platform that transforms MRIs into three-dimensional analyses of muscle to enable true precision. Springbok Analytics' advanced imaging technology identifies and measures each individual muscle, providing data to scientists, physical therapists, athletic trainers, and physicians to evaluate muscle function in relation to performance and injury management. The technology has numerous applications, including injury management, performance enhancement, and the treatment of musculoskeletal conditions.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

Perspective Therapeutics is a medical technology and radiopharmaceutical company focused on developing innovative treatments for cancer. The company specializes in a targeted approach to therapy, aiming to deliver remedies precisely where they are needed most. Utilizing a proprietary technology that incorporates the alpha-emitting isotope 212Pb, Perspective Therapeutics is working on applications that direct powerful radiation specifically to cancer cells through the use of specialized targeting peptides. This individualized method is designed to enhance treatment efficacy while minimizing collateral damage to healthy tissue, aligning with the company's commitment to addressing patients' unique medical needs.

BetterAge is a company dedicated to enhancing the health and well-being of older adults through innovative technology solutions. Founded on the principle that all adults can age well regardless of their current circumstances, BetterAge has developed a digital platform designed exclusively for this demographic. The platform provides personalized, objective content tailored to the needs of older adults, offering education and information about disease risks and actionable insights to support informed decision-making. By fostering a network of experts in aging services, health, and technology, BetterAge aims to create thriving communities where older adults can lead active and healthy lives.

AcuraStem is a biotechnology company based in Monrovia, California, founded in 2016. The company specializes in developing a precision medicine platform that utilizes complex cellular models derived from Amyotrophic Lateral Sclerosis (ALS) patients' cells. AcuraStem employs advanced cellular reprogramming and artificial intelligence technologies to create patient-specific treatments for neurodegenerative diseases. Their platform is designed to evaluate disease progression and test existing therapeutics, as well as combinations of therapeutic approaches, to identify effective treatments that could slow disease progression. The company's team includes PhDs, professors, tech entrepreneurs, and veterans from the drug industry, all working towards addressing the challenges posed by ALS.

University of Arkansas for Medical Sciences is an academic health center focusing on medical education, research, and clinical programs. It offers various medical services, including specialized care in areas such as women's health, cancer treatment, orthopedics, stroke care, and trauma.

University of Arkansas for Medical Sciences is an academic health center focusing on medical education, research, and clinical programs. It offers various medical services, including specialized care in areas such as women's health, cancer treatment, orthopedics, stroke care, and trauma.

Amydis is a privately-held pharmaceutical company dedicated to developing innovative diagnostic tools for detecting diseases linked to amyloid protein deposits. Its core technology involves novel compounds that fluoresce upon binding to amyloid proteins, enabling non-invasive diagnosis. Amydis' primary focus is on early-stage Alzheimer's disease detection, with other potential applications including Parkinson's disease, Creutzfeldt-Jakob disease, and various forms of amyloidosis. The company aims to provide faster, more accessible, and affordable diagnostic solutions compared to existing methods, contributing to better healthcare decisions for patients and their families.

Virtuoso Surgical focuses on creating advanced endoscopic robotic tools specifically designed for minimally invasive surgery. The company's innovative robotic surgery system enhances traditional endoscopy by allowing surgeons to navigate and operate in challenging anatomical areas with greater dexterity and precision. By utilizing needle-sized robotic arms, Virtuoso Surgical's technology not only simplifies the surgical process but also aims to improve patient outcomes while maintaining cost-effectiveness.

The Stark Neurosciences Research Institute is dedicated to improving outcomes for persons suffering from disorders of the nervous system.

On average, we spend a third of our lives in bed. Our self-positioning bed; the Korus™, combined with our AI-driven software, is designed to provide precise sleep therapies improving lifestyle and medical care that benefits sleep wellness and faster recovery at home.

Endomimetics is a company focused on developing advanced bio-nanometric coating technology, particularly for stents aimed at enhancing care for patients affected by kidney diseases. The company's innovative coating mimics human tissue, which helps minimize the need for additional surgeries and improves the longevity of stents. By reducing complications associated with the presence of foreign materials in the body, Endomimetics aims to provide better medical solutions for kidney disease patients, ultimately leading to improved care and patient outcomes.

Hillhurst Biopharmaceuticals specializes in developing innovative, liquid therapeutic gases for treating sickle cell disease. Their core technology enables the oral delivery of low-dose carbon monoxide, targeting the protective heme oxygenase system to reduce inflammation, prevent cell death, and halt hemoglobin polymerization. This approach addresses challenges associated with traditional inhaled gas therapies, such as caregiver exposure and imprecise dosing, ensuring accurate and safe administration.

Rivanna Medical, LLC is a medical technology company founded in 2010 and headquartered in Charlottesville, Virginia. The company specializes in the development and commercialization of Accuro, an advanced ultrasound-based system designed to enhance the application of spinal and epidural anesthesia through automated three-dimensional navigation of the lumbar spine. In addition to its primary focus on anesthesia, Rivanna Medical's technology also encompasses various imaging applications, including diagnostic imaging for musculoskeletal and abdominal anatomies. By leveraging innovative ultrasound technology, Rivanna Medical aims to lower healthcare costs, improve patient outcomes, and minimize the risks associated with radiation from traditional X-ray-based imaging.

Center for HIV Identification, Prevention, and Treatment Services is a research organisation that conducts HIV research. They offers customer support through email and phone contact.

L2P Research Labs is a preclinical contract research organization (CRO) that specializes in providing comprehensive research and development support. The company offers a range of preclinical and toxicology services, utilizing advanced technologies such as quantitative whole-body animal imaging, small animal ultrasound, MRI, and CT scans. L2P Research Labs also provides proprietary orthotopic and metastatic tumor models, enabling researchers to access a complete suite of research services tailored to their needs. Through its innovative approaches and state-of-the-art facilities, the company supports the advancement of scientific research in the fields of medicine and drug development.

BioCircuit Technologies, Inc. is a medical device company based in Atlanta, Georgia, founded in 2016. The company specializes in developing noninvasive electrophysiology devices that monitor, control, and repair peripheral nerves. By utilizing multi-electrode arrays and proprietary algorithms, BioCircuit's products enable clinicians to diagnose health conditions more effectively, track the progression of symptoms over time, and select tailored treatments for individual patients. This innovative approach enhances the ability of healthcare providers to address nerve-related health issues with greater precision and efficiency.

The University of Kentucky, founded in 1865, is a public, non-profit institution and Kentucky's flagship university. It is dedicated to enhancing lives through high-quality education, research, and service, with a strong emphasis on health care. The university offers a range of graduate and undergraduate programs, particularly in agriculture and mechanical fields. As a land grant institution, it assumes a vital leadership role in promoting diversity, inclusion, economic development, and overall human well-being within the community and beyond.

Rational Vaccines is a preclinical stage company focused on developing innovative vaccines to address herpes simplex virus-related diseases. The company is dedicated to creating live-attenuated viral immunotherapeutics and prophylactic vaccine candidates aimed at reducing the spread of the virus and improving the management of symptoms associated with herpes infections. Through its research, Rational Vaccines aspires to revolutionize the treatment, prevention, and diagnosis of herpes and related conditions, ultimately enhancing the quality of life for individuals affected by these diseases.

SINTX Technologies, Inc. is a biomaterial company specializing in the research, development, manufacturing, and commercialization of medical implant products made from silicon nitride. Founded in 1996 and headquartered in Salt Lake City, Utah, SINTX offers a range of ceramic-based biomaterial solutions applicable in various medical and industrial fields. The company primarily focuses on producing spinal implant products, marketed under the Valeo brand, which are used in cervical and thoracolumbar surgeries. SINTX operates an ISO 13485 certified manufacturing facility and collaborates with external partners, providing custom manufacturing and development of silicon nitride ceramics for both medical and non-medical applications. Its products are recognized for their biocompatibility, bioactivity, and excellent bone affinity, and have been successfully implanted in patients across the United States, Europe, Brazil, and Taiwan.

Rhaeos is a pioneering company that has developed the world's first wearable shunt monitor, designed to enhance the quality of care for patients with hydrocephalus. Utilizing a novel thermal biosensor, Rhaeos addresses a critical clinical need by offering noninvasive, wireless patches that detect fluid flow in various bodily systems, including blood, lymph, and cerebrospinal fluid. This innovative technology enables timely treatment for chronic medical conditions, particularly in the field of neurosurgery. Founded through collaborative efforts at Northwestern University, Rhaeos exemplifies a multidisciplinary approach, integrating expertise from engineering, medicine, and management to advance patient care.

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in New York, focused on developing innovative therapies for life-threatening diseases, particularly in the field of oncology. The company specializes in radiotherapies utilizing its alpha particle immunotherapy platform, which delivers radioisotopes through monoclonal antibodies to target and destroy cancer cells effectively. Its lead product candidate, Iomab-B, is undergoing a pivotal Phase III clinical trial as an induction and conditioning agent for patients over 55 with relapsed or refractory acute myeloid leukemia prior to hematopoietic stem cell transplantation. Additionally, Actinium is developing Actimab-A, which is in Phase II trials for newly diagnosed AML patients aged 60 and older, as well as Actimab-M for penta-refractory multiple myeloma currently in Phase I trials. The company also collaborates with Astellas Pharma to advance its research initiatives. Founded in 2000, Actinium Pharmaceuticals aims to address unmet medical needs in cancer treatment through its proprietary technologies.

Drexel University Dornsife School of Public Health is a public health school that provides education, conducts research, and partners with communities to improve the health of populations.

Omniose is an early-stage biotechnology company focused on the development of next-generation conjugate vaccines aimed at combating infectious diseases. The company specializes in pneumococcal conjugate vaccines that leverage proprietary in vivo conjugating technology, allowing for broader protection against various bacterial strains. By utilizing bioconjugation technology, Omniose's approach circumvents reliance on synthetic chemistry techniques, thereby enhancing the efficiency of vaccine development. This innovative platform supports the creation of polysaccharide-protein conjugate-based vaccines targeting multiple respiratory pathogens, including Streptococcus pneumoniae, ultimately enabling healthcare professionals to provide more effective treatment options for patients.

University of Minnesota Medical School educates students, provides patient care, and performs biomedical and clinical research. UMN Medical School offers medical, graduate, and undergraduate degree programs, as well as continuing professional development. The Medical School has two campuses based in the Twin Cities and Duluth, Minnesota. The Twin Cities campus is an interdisciplinary research center. The Duluth campus educates 130 first and second-year medical students committed to practicing in rural or American Indian communities.

Strykagen manufactures transforming diagnostics and therapeutics for life-threatening rare muscle diseases.

Boston University Chobanian & Avedisian School of Medicine is a school of medicine focus on treating disadvantaged and underserved populations.

Glyphic Biotechnologies is a biotechnology company focused on developing an advanced protein sequencing platform that aims to enhance the understanding of human biology and diseases. Recognizing that while DNA offers valuable biological insights, it is proteins that provide critical information about bodily functions, Glyphic Biotechnologies is creating a next-generation sequencing technology. This innovative platform is designed to increase binding affinity and improve consistency, ultimately facilitating the creation of personalized and precision cancer vaccines for diverse patient populations. By enabling scientists and researchers to perform single-molecule, massively parallel protein sequencing, the company aims to support the development of novel therapeutics and diagnostics, paving the way for significant advancements in biomedical research and healthcare.

ReShape Medical Inc. is a medical device company headquartered in San Clemente, California, specializing in non-surgical weight loss solutions. The company offers the ReShape Integrated Dual Balloon System, which employs dual balloon technology to aid weight loss in adults with a Body Mass Index (BMI) of 30-40 who have not achieved success with diet and exercise alone. This procedure is complemented by a personalized weight loss program that lasts one year. The company's product line includes the FDA-approved Lap-Band System, a minimally invasive treatment for obesity, and the investigational ReShape Vest System, designed to wrap around the stomach and induce weight loss without permanently altering patient anatomy. ReShape Medical's portfolio aims to provide effective alternatives to invasive surgical procedures for managing obesity and related metabolic diseases. The company operates as a subsidiary of EnteroMedics Inc., having undergone a name change in 2017.

Subtle Medical, Inc. is a healthcare technology company based in Menlo Park, California, specializing in AI-powered medical imaging solutions. Founded in 2017, the company develops innovative software products such as SubtleMR and SubtlePET, which are designed to enhance image quality in magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. These products utilize proprietary deep learning algorithms to reduce image noise and improve sharpness, thereby increasing efficiency and safety in clinical workflows. Subtle Medical's technology is FDA cleared and CE marked, and it operates on a vendor-agnostic AI infrastructure that integrates seamlessly with existing imaging systems. The company's mission is to enhance the quality, value, and accessibility of medical imaging by lowering costs, reducing imaging time, and minimizing radiation and contrast doses for patients.

Glyphic Biotechnologies is a biotechnology company focused on developing an advanced protein sequencing platform that aims to enhance the understanding of human biology and diseases. Recognizing that while DNA offers valuable biological insights, it is proteins that provide critical information about bodily functions, Glyphic Biotechnologies is creating a next-generation sequencing technology. This innovative platform is designed to increase binding affinity and improve consistency, ultimately facilitating the creation of personalized and precision cancer vaccines for diverse patient populations. By enabling scientists and researchers to perform single-molecule, massively parallel protein sequencing, the company aims to support the development of novel therapeutics and diagnostics, paving the way for significant advancements in biomedical research and healthcare.

Greenstone Biosciences is a drug discovery platform focused on accelerating the development of effective therapies for patients. By leveraging advanced technologies, including artificial intelligence and human-induced pluripotent stem cells, the company aims to transform the traditional drug discovery process, which is often slow and prone to high failure rates. Greenstone Biosciences seeks to create a rapid and integrated computational platform that can efficiently deliver safe and effective therapeutics, addressing diseases with significant unmet medical needs. Through its innovative approach, the company is dedicated to improving patient outcomes and advancing therapeutic options.

The Buck Institute is the nation’s first independent research facility focused solely on understanding the connection between aging and chronic disease. Their mission is to increase the healthy years of life. At the Buck Institute, world-class scientists work in a uniquely collaborative environment to understand how normal aging contributes to the development of conditions specifically associated with getting older such as Alzheimer’s and Parkinson’s diseases, cancer, stroke, osteoporosis, heart disease, diabetes, macular degeneration and glaucoma. Their interdisciplinary approach brings scientists from disparate fields together to develop diagnostic tests and treatments to prevent or delay these maladies. The stakes have never been higher. While it’s true that people are living longer, those “extra” years are often marked by disability and pain. In addition to personal hardship, there is also a cost to society. The financial burden of treating the chronic diseases of aging is expected to rise steadily as Baby Boomers get older. There is an urgency to Their mission.

Daxor Corporation is a medical device and biotechnology company based in New York, founded in 1970. It specializes in blood volume measurement, offering the BVA-100 Blood Volume Analyzer, the first FDA-approved instrument for the rapid and direct measurement of a patient's true blood volume. This device is utilized in diagnosing and managing various medical conditions, including congestive heart failure, critical care medicine, hypertension, and anemia. In addition to its core product, Daxor provides cryobanking services such as semen banking and blood storage, along with andrology and general laboratory testing services. The company also collaborates with the Uniformed Services University of the Health Sciences to research the effectiveness of its diagnostic tests in traumatic injury contexts. Daxor was previously known as Idant Corporation before rebranding in May 1973.

NeuroGeneces is a company that leverages advanced neuroscience, sleep expertise, and artificial intelligence to enhance cognitive healthspan through comprehensive brain health assessments. The company has developed a sleep performance device that utilizes machine learning algorithms to analyze patient EEG data, comparing it with a proprietary normative database to determine biological brain age. This innovative approach allows healthcare practitioners to objectively evaluate brain function and develop targeted intervention strategies. Additionally, the device monitors sleep quantity and quality, measures changes in heart rate variability, and aims to identify signs of neurodegeneration well before cognitive symptoms appear, enabling timely and effective interventions. By focusing on wellness and preventative care, NeuroGeneces aims to support users in optimizing their mental and physical performance.

Nexilico, Inc. is an early-stage biotechnology firm established in 2017 and headquartered in Albany, California. The company specializes in advancing microbiome and precision medicine through the development of innovative predictive computational platforms. These platforms enhance drug design and development, focusing on improving clinical outcomes in therapeutics. By pioneering next-generation in silico microbiome technologies, Nexilico aims to deepen the scientific understanding of microbiomes and their impact on health and disease. This knowledge enables Nexilico to create novel microbiome-based approaches that support clients in optimizing drug development processes and outcomes.

Boston Immune Technologies & Therapeutics, Inc. is a biopharmaceutical company focused on developing immune-based therapies for cancer and infectious diseases. Incorporated in 2011 and located in Winchester, Massachusetts, the company has created a platform that targets the tumor necrosis factor receptor 2 (TNFR2) oncogene and the specific population of TNFR2 regulatory T cells within the tumor microenvironment. This innovative approach aims to enhance immunotherapy strategies, particularly for chronic infectious diseases, by leveraging the body's immune system to combat various health challenges.

PediaMetrix Inc. is a healthcare technology company based in Rockville, Maryland, founded in 2018 by a team of entrepreneurs and scientists from Johns Hopkins, NIH, and Oxford. The company specializes in developing a digital tool aimed at improving pediatric head measurement and monitoring. Its primary product, SoftSpot, is a mobile application that utilizes artificial intelligence and computer vision to provide accurate measurements of infants' head shapes and monitor their growth patterns. The app offers parents instant quantitative analysis and personalized repositioning instructions to address flat head syndrome while enabling pediatricians to access comprehensive data for effective clinical decision-making. PediaMetrix's mission is to enhance healthcare outcomes for children by facilitating early detection and management of cranial abnormalities, ultimately aiming to reduce healthcare costs and improve overall pediatric care.

Talus Bio is a biotechnology startup focused on drug discovery and development, particularly targeting challenging cancer transcription factors. The company employs an innovative approach that integrates functional proteomics, automated biology, and machine learning. Their MARMOT platform utilizes AI, advanced proteomics, synthetic chemistry, and computational biology to design and analyze drugs, proteins, and genomics. This platform is designed to advance drug development for gene regulation in oncology, aiming to create small-molecule therapies that can effectively control gene expression in cancer cells.

The Medical College of Wisconsin, established in 1893 and located in Milwaukee, is dedicated to advancing education and research in the health sciences. It prepares the next generation of physicians, scientists, and healthcare professionals through a variety of graduate programs, including bioethics, healthcare technologies management, and pharmacology. The college employs a unique Discovery Curriculum that emphasizes personalized education, combining classroom instruction with hands-on clinical experiences guided by experienced faculty and medical technicians. The Student Teaching Assessment Resource Center (STAR) provides a platform for students and professionals to hone their clinical skills using advanced medical simulators. The college also offers financial aid opportunities and reduced tuition for Wisconsin residents. Its mission encompasses not only education but also the discovery and application of new biomedical knowledge, aiming to enhance community health and deliver high-quality patient care.

Tulane University, founded in 1834 and located in New Orleans, Louisiana, is a highly regarded independent research university known for its selective admissions and strong academic programs. As a member of the Association of American Universities, it emphasizes excellence in graduate and professional education alongside scholarly research. Tulane offers a diverse range of undergraduate, graduate, and professional degrees across multiple disciplines, including liberal arts, science and engineering, architecture, business, law, social work, medicine, and public health. The university boasts a robust research environment, supported by several specialized centers such as the Tulane Cancer Center and the Newcomb College Institute. Recognized by the Carnegie Foundation for its very high research activity, Tulane is among an elite group of institutions, representing only 2 percent of universities in the United States.

Jackson State University, established in 1877 and located in Jackson, Mississippi, is a historically black university (HBCU) that offers a diverse range of academic programs, including business, liberal arts, science, engineering, and education. The university is dedicated to enhancing the educational experience of its students through various support services, such as a recreational center, counseling, health services, and tutoring. Additionally, Jackson State University places a strong emphasis on career development, providing resources like career assessments, internship listings, resume writing assistance, and interview preparation through its career services center. As the Urban University of Mississippi, it aims to address challenges in urban communities through social work initiatives and a dedicated corps of student volunteers. Financial aid opportunities, including loans, grants, and scholarships, are available to students based on merit, need, and specific academic programs.

Morehouse School of Medicine, located in Atlanta, Georgia, is a distinguished institution focused on medical education, particularly for minority students. As a historically Black college and university (HBCU), it offers a range of degree programs, including medical degrees with specializations in fields such as Family Medicine, Internal Medicine, and Pediatrics, among others. In addition to its MD program, Morehouse provides master's degrees in Public Health and Biomedical Sciences, along with conducting significant research in areas like cardiovascular studies and health disparities. The institution emphasizes a commitment to diversity and offers scholarships to support disadvantaged students. The endowment fund managed by Morehouse School of Medicine plays a crucial role in funding scholarships, professorships, fellowships, and research initiatives, thereby enhancing its educational and public service missions.

The Avera McKennan Hospital School of Radiologic Technology in Sioux Falls, South Dakota, offers a 24 month Radiologic Technology program that is rooted in the Roman Catholic healing ministry of the Gospel. Avera McKennan strives to produce students who uphold Christian values throughout their medical career. The school's academics are designed to prepare students to take the American Registry of Radiologic Technology's certification exam. To be qualified to sit for the exam, students must have earned an associate's degrees. Since this degree does not have to be in Radiologic Technology, Avera McKennan participates with a number of colleges and universities throughout South Dakota to help its students earn their credentials to take the exam. Your instruction will be delivered through lectures, demonstrations and guided clinical experiences at the Sioux Falls Veterans Administration Center. Since your education will be completed in real hospitals, you will gain valuable work experience during your college life to prepare you for the demands of the career. Avera McKennan's coursework emphasizes the healing power of Christ's ministry. Students are expected to embody these qualities and be willing to dedicate their lives to helping others. To apply, students must submit an application, high school or college transcript, ACT scores and three letters of recommendation. Admissions are determined based on upon an applicant's character and willingness to succeed. For information on the availability of financial aid and other tuition assistance programs, please contact Avera McKennan.

The University of Utah, located in Salt Lake City, is the state's foremost public university and the only institution in Utah with a medical school. It offers a diverse array of undergraduate and graduate programs, encompassing over 100 undergraduate majors across disciplines such as architecture, business, education, engineering, fine arts, health careers, humanities, and social work, as well as more than 90 graduate degrees. In addition to its medical school, the University hosts a law school and a pharmacy school. Students are encouraged to engage in vibrant campus life through more than 400 clubs and organizations, alongside recreational activities and cultural events. Admission requirements include an application fee, transcripts, and standardized test scores, with a minimum high school GPA of 2.6. Financial aid is available based on both academic merit and financial need, with students required to complete the FAFSA to determine their eligibility for scholarships, loans, and grants.

University of Oklahoma Health Sciences Center, as a comprehensive academic health center, is to educate students, residents, and other trainees in professional and graduate programs to become Oklahoma’s future team of healthcare leaders, clinicians, researchers, and educators; to advance distinctive basic, translational, clinical, and population research; to innovate and commercialize discoveries; and to deliver exceptional patient care across the full breadth of adult, women’s, and children’s specialties.

Inherent Biosciences is a molecular diagnostics company focused on transforming the traditional trial and error approach in medicine. The company leverages its innovative epigenetic medicine platform to address various health challenges by identifying gene dysregulation and its associated pathways. By translating biological insights into actionable information, Inherent Biosciences aims to enhance treatment strategies for conditions such as pain, infertility, embryo quality, autism, rheumatoid arthritis, psoriatic arthritis, fetal heart disease, and COVID-19. This approach not only guides healthcare professionals in managing complex diseases but also seeks to provide personalized insights that empower patients in their health journeys.